FDA panel favors Glaxo, Ligand blood drug
Friday, May 30, 2008 - 12:42
in Health & Medicine
WASHINGTON (AP) -- Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline and Ligand Pharmaceuticals is effective for short-term use, despite reservations by FDA scientists....